Skip to main content

View full-text article in PMC

. 2011 Dec 30;17(1):341–354. doi: 10.3390/molecules17010341

Table 4.

Effects of sevoflurane postconditioning on serum and brain MDA, GSH concentrations.

Group	MDA		GSH
Group	Blood (nmol/mL)	Brain (nmol/g prot)	Blood (nmol/mL)	Brain (nmol/mg protein)
I	4.21 ± 0.21	3.15 ± 0.15	43.98 ± 3.08	58.32 ± 2.31
II	8.53 ± 0.37 ^b	7.04 ± 0.43 ^b	22.17 ± 1.43 ^b	20.61 ± 1.26 ^b
III	7.02 ± 0.42 ^c	5.82 ± 0.22 ^d	29.51 ± 1.24 ^d	32.51 ± 1.32 ^d
IV	5.97 ± 0.22 ^d	5.01 ± 0.27 ^d	35.66 ± 1.75 ^d	41.28 ± 1.85 ^d
V	4.88 ± 0.28 ^d	4.22 ± 0.17 ^d	40.71 ± 1.95 ^d	59.03 ± 2.08 ^d

^b p < 0.01, compared with group I; ^c p < 0.05, ^d p < 0.01, compared with group II.